Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
1.730
-0.040 (-2.26%)
At close: Jul 11, 2025, 4:00 PM
1.750
+0.020 (1.16%)
After-hours: Jul 11, 2025, 7:07 PM EDT
Aprea Therapeutics Market Cap
Aprea Therapeutics has a market cap or net worth of $9.57 million as of July 11, 2025. Its market cap has decreased by -57.54% in one year.
Market Cap
9.57M
Enterprise Value
-9.71M
1-Year Change
-57.54%
Ranking
Category
Stock Price
$1.73
Market Cap Chart
Since May 27, 2022, Aprea Therapeutics's market cap has decreased from $18.94M to $9.57M, a decrease of -49.46%. That is a compound annual growth rate of -19.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 9.57M | -46.48% |
| Dec 31, 2024 | 17.88M | 1.81% |
| Dec 29, 2023 | 17.56M | 0.11% |
| Dec 30, 2022 | 17.54M | -7.36% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 709.79B |
| Johnson & Johnson | 379.41B |
| AbbVie | 344.45B |
| Novo Nordisk | 316.64B |
| UnitedHealth Group | 271.70B |
| Novartis AG | 243.81B |
| Abbott Laboratories | 232.44B |
| AstraZeneca | 223.49B |